Navigation Links
Heska Introduces New Lactate Meter Analyzer
Date:3/1/2011

LOVELAND, Colo., March 1, 2011 /PRNewswire/ -- Heska Corporation (Nasdaq: HSKA; "Heska"), a leading provider of advanced diagnostic and specialty products to veterinarians, today announced the addition of a lactate meter analyzer to its portfolio of in-clinic blood analyzers.

(Logo:  http://photos.prnewswire.com/prnh/20000622/HESKALOGO)

Among other features, the handheld portable analyzer is used to measure lactate, and is ideal for both in-clinic and field use. It provides a lactate assay solution to complement the VitalPath® and DRI-CHEM® Analyzers for complete blood analysis.

"Heska is pleased to announce another product collaboration with Roche," commented Michael McGinley, President and Chief Operating Officer of Heska. "This new lactate meter analyzer will complement Heska's full range of blood analyzers, and is another example of our commitment to innovation within the veterinary industry."

About Heska

Heska Corporation (Nasdaq: HSKA) sells advanced veterinary diagnostic and other specialty veterinary products. Heska's state-of-the-art offerings to its customers include diagnostic and monitoring instruments and supplies as well as single use, point-of-care tests, vaccines and pharmaceuticals. The company's core focus is on the canine and feline markets where it strives to provide high value products and unparalleled customer support to veterinarians. For further information on Heska and its products, visit the company's website at www.heska.com.

Forward-Looking Statements

This announcement contains forward-looking statements regarding Heska's future financial and operating results. These statements are based on current expectations and are subject to a number of risks and uncertainties including risks related to Heska's reliance on a third party, Roche Diagnostics, to supply the lactate meter analyzers and affiliated consumables of appropriate quality and quantity; competition; uncertainties regarding Heska's ability to successfully commercialize new products; uncertainties regarding Heska's ability to market, sell and distribute products; uncertainties regarding the performance of products in field use as compared to current expectations; uncertainties regarding the outcome of any collaborations between Heska and any third party, including Roche; risks related to relying on the reputation of Heska, Roche or any other entity, which is subject to interpretation and may change over time; uncertainties related to the future development efforts of any third party; and the risks set forth in Heska's filings and future filings with the Securities and Exchange Commission, including those set forth in Heska's Annual Report on Form 10-K/A for the year ended December 31, 2009 and Quarterly Report on Form 10-Q for the quarter ended September 30, 2010.


'/>"/>
SOURCE Heska Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Heska to Present Live, Online at RetailInvestorConferences.com
2. Heska to Present at Sidoti Micro-Cap Conference
3. Heska Corporation Announces Stockholder Approval of Reverse Split
4. Webcast Alert: Heska Corporations Special Meeting of Stockholders Webcast
5. Heska Corporation Awards $25,000 Grand Prize to Pets Forever
6. Heska Announces Q310 Results
7. Heska Announces First Installation of New Blood Gas & Electrolyte Analyzer
8. Heska to Present at SunTrust Robinson Humphrey 1st Annual Veterinary Conference
9. Webcast Alert: Heska Announces Fourth Quarter and Year-End 2009 Earnings Conference Call Webcast
10. Heska Announces Extension of Credit Agreement With Wells Fargo
11. Heska Announces Supply Agreement With Roche Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016  Consumers have taken ... regulators/payers have placed more emphasis on patient outcomes. ... support programs in the pharmaceutical industry have evolved ... Consequently, pharmaceutical companies are focusing on becoming more ... providing products and services that improve health. ...
(Date:6/24/2016)... Research and Markets has ... 2015-2025: Applications, Technologies, Forecasts" report to their ... Electronics, Smart Skin, Structural Health Monitoring, Composite Smart ... electronics involves electronic and/or electrical components and circuits ... structures such as vehicle bodies or conformally placed ...
(Date:6/24/2016)... 2016 According to a new ... Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, ... Mode of Purchase (Retail, Non-Retail) - Trends & Global ... the market for the forecast period of 2016 to ... Billion by 2021 from USD 1.65 Billion in 2016, ...
Breaking Medicine Technology:
(Date:6/26/2016)... , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal ... personalized through a fitness app. The fitness app plans to fix the two major problems ... offer a one size fits all type program , They don’t eliminate all ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... 2016 , ... First Choice Emergency Room , the largest network of ... Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased to ... said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
Breaking Medicine News(10 mins):